Goldman Sachs Group Inc Sana Biotechnology, Inc. Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
A detailed history of Goldman Sachs Group Inc transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 682,092 shares of SANA stock, worth $2.72 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
682,092
Previous 303,234
124.94%
Holding current value
$2.72 Million
Previous $827,000
192.74%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding SANA
# of Institutions
196Shares Held
126MCall Options Held
194KPut Options Held
353K-
Flagship Pioneering Inc. Cambridge, MA25MShares$99.8 Million32.83% of portfolio
-
Baillie Gifford & CO11.4MShares$45.6 Million0.03% of portfolio
-
Black Rock Inc. New York, NY11MShares$44.1 Million0.0% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$40.6 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.13MShares$36.4 Million0.0% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $759M
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...